An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome.
about
Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in KoreaAdvances and challenges in the management of complement-mediated thrombotic microangiopathiesComplement System Part II: Role in ImmunitySuccess of eculizumab in the treatment of atypical hemolytic uremic syndrome.An international consensus approach to the management of atypical hemolytic uremic syndrome in children.Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.Efficacy and safety of therapeutic plasma exchange by using apheresis devices in pediatric atypical hemolytic uremic syndrome patients.The long-term outcomes of atypical haemolytic uraemic syndrome: a national surveillance study.Anti-complement-factor H-associated glomerulopathies.First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients.Atypical Hemolytic Uremic Syndrome: A Brief Review.Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patientsCase report - atypical hemolytic uremic syndrome triggered by influenza BAtypical hemolytic uremic syndrome: a clinical conundrum.Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS.Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced.Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome.Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome.Atypical hemolytic uremic syndrome and eculizumab therapy in children.Eculizumab Dosing in Infants.
P2860
Q26739894-629403BF-63B4-4024-A0EE-E80DE069F0FBQ26796453-C01D52DE-5731-486D-9CB1-3BBADCC116E7Q28263460-E6F823F7-C886-45B1-B0C6-8256F6E6434DQ33418632-F7DD560F-0710-4628-B904-99B65102113CQ33421861-CC4DFE6E-0CD6-4C6A-B533-BFF09F2E6435Q33424274-5C5796BC-93A1-40B8-8E84-811C56011224Q33424757-568F5F3D-B021-449C-9588-6C6A398F6953Q33428892-317B8F66-E300-4EAC-8F31-23202ECDE177Q33434103-FFF17EA4-8AEA-4F85-A2EF-BE7EB9A2FF2EQ33435451-86756D1E-80EB-4F82-8F2F-8FFC1A820E6CQ33442794-985BA843-FD1D-4621-BEBE-6245714A1D97Q36241014-EB08B609-E64C-434B-9646-5C71596F04F9Q36315444-1BBEA777-08B4-4AFA-B6DA-5D25A20D236BQ38824060-C5EF1DD5-B15E-455E-A267-B9749FC6A990Q40324683-7B846F90-04DC-4700-86B1-39B345292FE9Q42263820-7385E624-7C92-406A-B934-2C6C37AF151FQ47102552-826123C0-32C8-45EF-A127-1C14EABBBCD6Q47225732-34F0EFDD-245C-4BD0-BC43-03FD0A846A46Q48146844-D6EE1091-99D3-459E-A8A1-A08DA5FBA9DCQ54207419-65B173E4-1F8A-423C-9B78-52A0837C4F2EQ55024128-FC98DDF9-39E0-42B1-8886-78AFB4CAF486
P2860
An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
An audit analysis of a guideli ...... al) hemolytic uremic syndrome.
@ast
An audit analysis of a guideli ...... al) hemolytic uremic syndrome.
@en
type
label
An audit analysis of a guideli ...... al) hemolytic uremic syndrome.
@ast
An audit analysis of a guideli ...... al) hemolytic uremic syndrome.
@en
prefLabel
An audit analysis of a guideli ...... al) hemolytic uremic syndrome.
@ast
An audit analysis of a guideli ...... al) hemolytic uremic syndrome.
@en
P2093
P2860
P1433
P1476
An audit analysis of a guideli ...... al) hemolytic uremic syndrome.
@en
P2093
C Mark Taylor
Carmine Pecoraro
Chantal Loirat
Christoph Licht
Craig Langman
Daniel Landau
Ekaterini Siomou
Gema Ariceta
Jelena Stojanovic
Johan Vande Walle
P2860
P2888
P304
P356
10.1007/S00467-014-2817-4
P577
2014-05-11T00:00:00Z
P5875
P6179
1008825617